BACKGROUND:: Endovascular treatment has become the preferred choice for craniocervical vascular diseases, including detachable balloons, coils, liquid embolic agent, and covered stent. The covered stent has two advantages: a higher rate of complete occlusion and lower recanalization rate. OBJECTIVE:: To introduce several kinds of covered stents in China and to investigate the curative effects of covered stents on craniocervical artery aneurysms and carotid cavernous fistula. METHODS:: A computer based search of Wanfang database was performed for relevant articles published between 1998-01 and 2010-12 using the keywords of “covered stent, biocompatibility, aneurysms, carotid cavernous fistula”. Repetitive articles and Meta analysis were excluded. RESULT S AND CONCLUSION:: Jostent stent produced by Abbott, USA, and Willis stent produced by Shanghai Mini-invasive Company are commonly used in clinical neurosurgery. Jostent stent has a good biocompatibility and expansibility, and its porous structure can reduce cell spreading, and prevent platelet aggregation and inflammatory cell migration so as to reduce the probability of secondary thrombosis and vascular stenosis. However, the disadvantages of Jostent stent are limitations used in intracranial arteries: the bending angles of the artery cannot be very sharp, and non-occlusive perforating arteries and branches cannot exist around the lesion. Willis stent that completely changes the traditional concept about endovascular treatment of intracranial aneurysms has certain flexibility in the entire stent system which contributes to the intracranial vascular system, in particular, the siphon segment of carotid artery. Because of its simple operation and satisfactory effects, Willis stent offers a new direction for endovascular therapy development.Han DF, Kong XF, Tuerxun·Shabier.Covered stents for craniocervical vascular diseases. Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu. 2011;15(21): 3957-3960. [http://www.crter.cn http://en.zglckf.com](Figure is included in full-text article.)